NEW YORK - IN8bio, Inc. (Nasdaq: INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies with a current market capitalization of $23.42 million, has announced encouraging Phase ...

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

CHEYENNE – Upsilon Chapter of Delta Kappa Gamma will hold its 41st book sale next month in the former Big Lots in Cheyenne Plaza, 3501 E. Lincolnway, next to Trampoline ...

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...

Phi Gamma Delta is now prohibited from participating in activities such as recruitment, socials and meetings as the ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

The trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.

UCF's Phi Gamma Delta is suspended amid an investigation into alleged use of antisemitic symbols during hazing.

University of Central Florida Fraternity Banned Due to Hazing Involving Nazi Swastika, Phi Gamma Delta, UCF, antisemitism ...

NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...